2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide

C110H167N27O8 — CID 157488419

IUPAC2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide
SMILESCC(C)N1C[C@@H](C)[C@H](NC(=O)c2cc(C3CC3)[nH]n2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2cc(C3CC3)ncn2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2cnnc(C3CC3)c2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2ncc(C3CC3)cn2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2nccc(C3CC3)n2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2cnnc(C3CC3)c2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2coc(C3CC3)n2)C1
InChIInChI=1S/5C16H24N4O.C15H24N4O.C15H23N3O2/c2*1-10(2)20-8-11(3)15(9-20)18-16(21)13-6-14(12-4-5-12)19-17-7-13;1-10(2)20-8-11(3)14(9-20)19-16(21)15-17-6-13(7-18-15)12-4-5-12;1-10(2)20-7-11(3)15(8-20)19-16(21)14-6-13(12-4-5-12)17-9-18-14;1-10(2)20-8-11(3)14(9-20)19-16(21)15-17-7-6-13(18-15)12-4-5-12;1-9(2)19-7-10(3)14(8-19)16-15(20)13-6-12(17-18-13)11-4-5-11;1-9(2)18-6-10(3)12(7-18)16-14(19)13-8-20-15(17-13)11-4-5-11/h2*6-7,10-12,15H,4-5,8-9H2,1-3H3,(H,18,21);6-7,10-12,14H,4-5,8-9H2,1-3H3,(H,19,21);6,9-12,15H,4-5,7-8H2,1-3H3,(H,19,21);6-7,10-12,14H,4-5,8-9H2,1-3H3,(H,19,21);6,9-11,14H,4-5,7-8H2,1-3H3,(H,16,20)(H,17,18);8-12H,4-7H2,1-3H3,(H,16,19)/t11-,15+;11-,15-;11-,14-;11-,15-;11-,14-;10-,14-;10-,12+/m0111110/s1
InChIKeyBWZGIQZSUHSROE-QUDOMHNVSA-N
MW1995.73 g/mol
LogP12.82
Rot. Bonds28

About 2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide

2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide (PubChem CID 157488419) has the molecular formula C110H167N27O8 and a molecular weight of 1995.73 g/mol. Its IUPAC name is 2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide.

Molecular Properties

Compound Name2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide
PubChem CID157488419
Molecular FormulaC110H167N27O8
Molecular Weight1995.73 g/mol
Exact Mass1994.35
IUPAC Name2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide
SMILESCC(C)N1C[C@@H](C)[C@H](NC(=O)c2cc(C3CC3)[nH]n2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2cc(C3CC3)ncn2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2cnnc(C3CC3)c2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2ncc(C3CC3)cn2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2nccc(C3CC3)n2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2cnnc(C3CC3)c2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2coc(C3CC3)n2)C1
InChIInChI=1S/5C16H24N4O.C15H24N4O.C15H23N3O2/c2*1-10(2)20-8-11(3)15(9-20)18-16(21)13-6-14(12-4-5-12)19-17-7-13;1-10(2)20-8-11(3)14(9-20)19-16(21)15-17-6-13(7-18-15)12-4-5-12;1-10(2)20-7-11(3)15(8-20)19-16(21)14-6-13(12-4-5-12)17-9-18-14;1-10(2)20-8-11(3)14(9-20)19-16(21)15-17-7-6-13(18-15)12-4-5-12;1-9(2)19-7-10(3)14(8-19)16-15(20)13-6-12(17-18-13)11-4-5-11;1-9(2)18-6-10(3)12(7-18)16-14(19)13-8-20-15(17-13)11-4-5-11/h2*6-7,10-12,15H,4-5,8-9H2,1-3H3,(H,18,21);6-7,10-12,14H,4-5,8-9H2,1-3H3,(H,19,21);6,9-12,15H,4-5,7-8H2,1-3H3,(H,19,21);6-7,10-12,14H,4-5,8-9H2,1-3H3,(H,19,21);6,9-11,14H,4-5,7-8H2,1-3H3,(H,16,20)(H,17,18);8-12H,4-7H2,1-3H3,(H,16,19)/t11-,15+;11-,15-;11-,14-;11-,15-;11-,14-;10-,14-;10-,12+/m0111110/s1
InChIKeyBWZGIQZSUHSROE-QUDOMHNVSA-N
XLogP12.82
TPSA409.99 Ų
H-Bond Donors8
H-Bond Acceptors27
Rotatable Bonds28
Heavy Atoms145
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001995.73
LogP ≤ 512.82
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1027

Analyze 2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide?
The IUPAC name of 2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide (CID 157488419) is 2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide.
What is the SMILES notation for 2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide?
The canonical SMILES for 2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide is CC(C)N1C[C@@H](C)[C@H](NC(=O)c2cc(C3CC3)[nH]n2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2cc(C3CC3)ncn2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2cnnc(C3CC3)c2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2ncc(C3CC3)cn2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2nccc(C3CC3)n2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2cnnc(C3CC3)c2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2coc(C3CC3)n2)C1.
What is the InChIKey of 2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide?
The InChIKey is BWZGIQZSUHSROE-QUDOMHNVSA-N. The full InChI is InChI=1S/5C16H24N4O.C15H24N4O.C15H23N3O2/c2*1-10(2)20-8-11(3)15(9-20)18-16(21)13-6-14(12-4-5-12)19-17-7-13;1-10(2)20-8-11(3)14(9-20)19-16(21)15-17-6-13(7-18-15)12-4-5-12;1-10(2)20-7-11(3)15(8-20)19-16(21)14-6-13(12-4-5-12)17-9-18-14;1-10(2)20-8-11(3)14(9-20)19-16(21)15-17-7-6-13(18-15)12-4-5-12;1-9(2)19-7-10(3)14(8-19)16-15(20)13-6-12(17-18-13)11-4-5-11;1-9(2)18-6-10(3)12(7-18)16-14(19)13-8-20-15(17-13)11-4-5-11/h2*6-7,10-12,15H,4-5,8-9H2,1-3H3,(H,18,21);6-7,10-12,14H,4-5,8-9H2,1-3H3,(H,19,21);6,9-12,15H,4-5,7-8H2,1-3H3,(H,19,21);6-7,10-12,14H,4-5,8-9H2,1-3H3,(H,19,21);6,9-11,14H,4-5,7-8H2,1-3H3,(H,16,20)(H,17,18);8-12H,4-7H2,1-3H3,(H,16,19)/t11-,15+;11-,15-;11-,14-;11-,15-;11-,14-;10-,14-;10-,12+/m0111110/s1.
What are the key properties of 2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide?
2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide has a molecular weight of 1995.73 g/mol, XLogP of 12.82, 28 rotatable bonds, 8 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide is sourced from PubChem (CID 157488419), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).